Peter Goadsby, MD, PhD, FRS
Professor of Neurology and Neurologist
Dr. Peter J. Goadsby is one of the world’s leading headache neurologists and researchers, and a professor at King’s College London and the University of California, Los Angeles (UCLA). Dr. Goadsby is on the board of directors for the American Headache Society, as well as the American Migraine Foundation, in addition to serving on the American Registry Migraine Research (ARMR) scientific advisory board and executive committee. Dr. Goadsby is also a trustee for The Migraine Trust. He was one of the first to explore CGRP (calcitonin gene-related peptide), the protein known for its involvement in migraine. This discovery has been instrumental in creating the new class of medications CGRP receptor antagonists, including Aimovig, Ajovy, Emgality, and Vyepti.